Cytostatic Effect of the Hypothalamic Cytokine PRP-1 is Mediated by mTOR and cMyc Inhibition in High Grade Chondrosarcoma

Author： Galoian Karina   Temple Thomas   Galoyan Armen  

Publisher： Springer Publishing Company

ISSN： 0364-3190

Source： Neurochemical Research, Vol.36, Iss.5, 2011-05, pp. : 812-818

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Effect of Combination Treatment of Rapamycin and Isoflavones on mTOR Pathway in Human Glioblastoma (U87) Cells

By Puli Shilpa   Jain Aditi   Lai James   Bhushan Alok  

Neurochemical Research, Vol. 35, Iss. 7, 2010-07 ,pp. : 986-993

Springer Publishing Company

Access to resources Recommend Favorite

Targeting mTOR complex 1 to treat neurological and psychiatric manifestations of tuberous sclerosis complex

By Krueger Darcy A   Franz David Neal  

Future Neurology, Vol. 6, Iss. 2, 2011-03 ,pp. : 261-271

Future Medicine

Access to resources Recommend Favorite

Warming Up to New Possibilities with the Capsaicin Receptor TRPV1: mTOR, AMPK, and Erythropoietin

By  

Current Neurovascular Research, Vol. 14, Iss. 2, 2017-06 ,pp. : 184-189

Bentham Science Publishers

Access to resources Recommend Favorite

Neuroprotective Action of Hypothalamic Peptide PRP-1 at Various Time Survivals Following Spinal Cord Hemisection

By Galoyan Armen   Sarkissian John   Chavushyan Vergine   Sulkhanyan Ruben   Avakyan Zaruhi   Avetisyan Zubeida   Grigorian Yuri   Abrahamyan Davit  

Neurochemical Research, Vol. 30, Iss. 4, 2005-04 ,pp. : 507-525

Springer Publishing Company

Access to resources Recommend Favorite

mTOR as a potential treatment target for epilepsy

By Wong Michael  

Future Neurology, Vol. 7, Iss. 5, 2012-09 ,pp. : 537-545

Future Medicine

Access to resources Recommend Favorite